Discontinued — last reported Q3 '18
An increase typically signals recent acquisition activity, while a decrease may indicate divestitures or impairment charges taken against previously acquired assets.
This metric represents the net change in goodwill allocated to the Diagnostics and Genomics segment due to business comb...
Comparable to 'Goodwill and Intangible Asset Adjustments' reported by life science peers during periods of M&A activity.
a_segment_diagnosticsandgenomicssolutions_goodwill_transfers